Stock since the trade -3.1% · S&P 500 -0.2% · to Oct 1 Traded 53 days after results
Becton Dickinson's Chief Revenue Officer sold $14K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade -6.4% · S&P 500 -0.3% · to Oct 1 Traded 20 days after results Stock 35% above its 52-week low and 9% below its high, after a 23% rise in the previous month
20K → 20K shares held −1% of their stake
Becton Dickinson's Chief Revenue Officer sold $31K of Becton Dickinson shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.
Stock since the trade +12.1% · S&P 500 +3.4% · to Oct 1 Traded 10 days before results
Becton Dickinson's Chief Revenue Officer sold $12K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade +14.2% · S&P 500 +4.8% · to Oct 1 Traded 50 days after results
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade +20.5% · S&P 500 +1.8% · to Oct 1 Traded 19 days after results Stock within 4% of its 52-week low
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade +18.5% · S&P 500 +6.8% · to Oct 1 Traded 10 days before results Stock at its 52-week low
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.
Officer sold ~$12K of Becton Dickinson
Scheduled in advance6mo ago Officer sold ~$14K of Becton Dickinson
Automatic sale7mo ago Stock since the trade -12.5% · S&P 500 +10.3% · to Oct 1 Traded 14 days before results
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade -9.3% · S&P 500 +10.7% · to Oct 1 Traded 50 days after results
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. Nobody planned it ahead of time.
Stock since the trade -7.2% · S&P 500 +12.3% · to Oct 1 Traded 25 days after results
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. Nobody planned it ahead of time.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Stock since the trade -4.8% · S&P 500 +11.5% · to Oct 1 Traded 10 days before results
8,302 → 8,245 shares held −1% of their stake
Becton Dickinson's & President, Life Sciences sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.